Church & Dwight (CHD) Barclays 17th Annual Global Consumer Staples Conference summary
Event summary combining transcript, slides, and related documents.
Barclays 17th Annual Global Consumer Staples Conference summary
8 Jul, 2026Strategic growth model and performance
Targets 4% annual organic growth, with 3% domestic, 8% international, and 5% specialty products contributions.
Raised organic growth target from 3% to 4% based on a 10-year average of 4.2%.
Seven power brands account for 70% of revenues and profits, with $6 billion in sales, 78% domestic and 17% international.
E-commerce sales have grown from 1% in 2015 to 21% today, expected to reach 30% by decade's end.
Consistent gross margin expansion targeted at 25-50 basis points annually.
Innovation, portfolio, and acquisitions
Balanced portfolio: 37% value, 63% premium, enabling resilience in varied economic climates.
Low private label exposure and strong online presence support stability.
New product launches include Deep Clean detergent, Hardball lightweight litter, Batiste Touch and Sweat, Power Sheets, and TheraBreath antiseptic mouthwash.
Acquisition criteria: category leadership, growth above 4%, high margins, asset-light, synergy potential, and long-term sustainability.
Actively seeking acquisitions, with significant financial capacity for deals up to $5 billion.
Financial outlook and capital allocation
2024 outlook: 3.5% reported growth, 4% organic, 100-110 bps gross margin expansion, 8-9% EPS growth, and over $1 billion in cash from operations.
Free cash flow conversion averages 119% over 10 years; recent investments have temporarily reduced this but are expected to normalize.
Capital allocation priorities: M&A, CapEx, new product development, debt reduction, and shareholder returns.
CapEx expected to return to 2% of sales as capacity projects conclude.
Latest events from Church & Dwight
- Strong 2024 growth, innovation, and global expansion drive confidence in future performance.CHD
Consumer Analyst Group of New York Conference (CAGNY ) 20259 Jul 2026 - Q3 sales and margin gains offset by a $357.1M vitamin impairment; outlook remains positive.CHD
Q3 20249 Jul 2026 - 2025 targets 3–4% organic sales and 7–8% EPS growth, fueled by innovation and global expansion.CHD
Q4 2024 & Investor Day 20258 Jul 2026 - 2026 targets 3%-4% organic growth and 5%-8% EPS growth, led by Power Brands and innovation.CHD
Consumer Analyst Group of New York Conference (CAGNY) 20268 Jul 2026 - 2026 targets 3–4% organic sales growth, 5–8% EPS growth, and 100 bps margin expansion.CHD
Q4 2025 & Analyst Day 20268 Jul 2026 - Full-year outlook cut as sales and EPS fall, with strategic actions to reduce tariff risk by 80%.CHD
Q1 20258 Jul 2026 - 2026 targets 3–4% organic sales and 5–8% EPS growth, driven by innovation and power brands.CHD
23rd annual dbAccess Global Consumer Conference2 Jun 2026 - Q1 2026 saw 5% organic growth, margin expansion, and EPS up 4.4%, with guidance reaffirmed.CHD
Q1 20265 May 2026 - Key votes include director elections, executive pay, auditor ratification, and a written consent proposal.CHD
Proxy filing19 Mar 2026